Pay in 4 interest-free payments of $88.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Pyridaben-d13 (4-tert-butyl-d9-benzyl-2
AS10kTI03-2A
000ug/mL NICKEL 500mL
provided it is in the [WOF5]-2 form
7000 series MODIFIED MICROLITER™ syringes are certified to ± 1
EC UHPLC column (analytical), NUCLEODUR Phenyl-Hexyl, 1.8 µm, 30x3 mm NIST Pyridaben-d13 (4-tert-butyl-d9-benzyl-2This hydrophobic phase is based on high purity NUCLEODUR silica gel and modified with phenylhexyl. This RP phase gives an alternative selectivity in comparison to classical C18 modifications. Separation principle based on two retention mechanisms interactions and hydrophobic interactions. Due to low bleeding characteristics this UHPLC phase is suitable for LC MS. Technical Data Downloads Brand NUCLEODUR Pore size 110 Specific surface according to BET